IntroductIon
The current issue covers a new and comprehensive set of guidelines developed by personnel from ISCCM, for its members and for other clinicians. This accompanying comment is an evidence-free opinion suggesting how a practicing clinician could evaluate and use these guidelines. The clinician should review the strengths and weaknesses of all guidelines by using a simple 4-point pragmatic approach.
• Trust but verify section • Obsessively follow pragmatic protocols to enhance safety • Largely follow other guidelines based on high-quality evidence • Resist slavishly following other guidelines based on poorquality evidence.
trust b u t VerIfy
The clinician should countercheck at least two aspects of each and every guideline, regardless of the quoted strength of evidence or the level of recommendation. The first, is the guideline based on a clinical outcome; and, the second, is the guideline supported by data from adequately powered randomized controlled trials (RCTs). The clinician should also verify the process of development of the guidelines.
The clinician should first check whether the recommendation is based on a surrogate or physiological outcome alone or it has demonstrated clinical benefit. Box 1 shows the differences between these two outcomes. Those with demonstrated clinical benefit are more reliable and beneficial to patients. Those with only physiological or surrogate benefit should be seen as conditional recommendations. In conditional, one awaits future data on clinical benefit. If a recommendation is based on a proven physiological benefit but has been demonstrated as not to improve clinical outcomes, the guideline should be assumed to be of questionable value. Example of such guidelines include the use of recruitment maneuvers in ARDS (improve oxygenation) or the use of erythropoietin or colony-stimulating factors (improve hemoglobin and WBC), but these interventions do not have further improvement in the clinical outcomes listed in Box 1. Use of such guidelines should be individualized to the specific clinical situation or patient. A couple of examples, in the deep venous thrombosis (DVT) guidelines, most of the studies focus on detection of DVT by venous Doppler and simply assume that this translates into clinical benefit. In the central venous catheter guidelines, the guidelines concentrate on mechanical complications, infection and thrombosis, and almost none evaluates the impact of these on clinical outcomes.
The second aspect, the clinician should check, is if the level of evidence is strong. The most reliable are adequately powered RCTs with clinical outcomes.
Interpretation of data and trials requires some effort and training. Box 2 gives a suggested approach to evaluation of an RCT. It is a mistake on the part of the reader to assume that strong recommendations and high levels of evidence imply that the recommendation has proven clinical benefit. There are many common errors in interpreting data. Box 3 gives extreme examples of common pitfalls in interpreting data and coming to erroneous recommendations. The common errors are mistaking an association or a correlation for causation, mistaking a hypothesis for a conclusion and basing a conclusion on post-hoc or subgroup analysis of data.
The process of developing guidelines is difficult and generates significant ambiguity. A series of guidelines have been proposed (Box 4). The reader should check if the creation of the guidelines complies with the standards of the Institute of Medicine of the National Academies. 1 These guidelines are demanding and surveys have shown that most guidelines development groups do not meet the required standards. 2
obsessIVely follow PragmatIc Protocols to enhance safety
The primary role of ICUs is to stabilize vulnerable patients while the disease process is reversed. These patients are vulnerable to multiple adverse events, and safety standards to prevent them are paramount. Guidelines have been instrumental in framing these safety standards. The early guidelines by the pediatricians, the medical societies and the anesthetists laid the foundation for the safety standards that now exist, and it is these safety standards that minimize inadvertent and preventable patient harm. [3] [4] [5] In intensive care, guidelines for safe conduct of procedures, for preventions of drug or fluid administration errors, or for infection prevention, etc. should be obsessively followed. It is inappropriate to demand high-quality clinical outcome data for these practices.
Indian Journal of Critical Care Medicine, January 2020;24(Suppl 1) The error in the above example is that a post-hoc analysis is changing the interpretation and conclusion of the election For example, checking the drugs labels and doses before they are administered, checking that laryngoscopes are working before starting an intubation, and handwashing prior to touching any indwelling device, are obvious and self-explanatory enough to be blindly followed without scientific backing. All ICUs should develop and document their pragmatic safety procedures and the compliance to these requirements should be close to 100%.
S3

largely follow other guIdelInes based o n hIgh-qualIty eVIdence
We are now in an era where many of our practices have been tested in large RCTs with clinical outcomes. Unfortunately, the majority of these trials have been negative. 6 Recommendations that are based on such trials should be widely implemented by practitioners in ICUs. Examples include low tidal volume ventilation in acute respiratory distress syndrome (ARDS) and prone-position ventilation in severe ARDS, restrictive use of packed red blood cells (PRBCs), and mean arterial blood pressure targets of 65 mmHg among many others. Clinicians should be aware of these major trials and following the critical care sections of the large journals is the simplest way of staying up to date. Compliance of recommendations made on the basis of these RCTs should be high, ~ 90-100%, but the clinician should individualize their implementation according 
resIst slaVIshly followIng other guIdelInes based o n Poor-qualIty eVIdence
This recommendation is probably going to meet with a fair bit of resistance from clinicians and guideline developers and, therefore, warrants some explanation. As explained in the "trust but verify" section, a lot of guidelines are based on potentially erroneous interpretation of data. In the absence of robust data of clinical outcomes from RCTs, guideline developers feel obliged to give some form of recommendation. This may be accompanied by a statement that the recommendation is weak and the level of evidence is poor, but it invariably gets translated into something that must be followed. This leads to two problems. The potential for harm, and pressurizing clinicians to follow practices they do not believe. An unfortunate reality of most guidelines is that they are based on educated and biased guesses of experts based on poorquality data. Many of these are simply backed by tradition and habit. As the saying goes, "the chains of habit are too small to be noticed, until they become too strong to be broken". A guideline based on tradition and habit can simply end up reinforcing that practice, independent of its scientific validity. They also lead to clinicians ignoring the lack of scientific validation by citing "the guidelines" to justify their intervention or confirmation biases.
Harm has been demonstrated in the blind use of guidelines in ICU patients 8 and in perioperative patients. 9 It is widely accepted that the opiate crisis in USA was amplified by well-meaning but flawed clinical practice guidelines that overemphasized benefit and downplayed harm. This bias in guidelines has been repeatedly demonstrated earlier too. 2 When using guidelines based on poor evidence or on surrogate endpoints, a compliance approaching 100% could suggest failure of the part of clinician in individualizing care to the specific patient. Such a clinician is at risk of becoming a slave to the guidelines-an unfortunate and unintended consequence of the contemporary culture of guideline-based medicine. We have discussed the limitation of guidelines in more detail elsewhere 10 conclusIon This opinion piece attempts to navigate the evolving world of guidelines and suggests a four-pronged approach to their use. First, trust but verify by referring to the studies behind the recommendation. Second, obsessively follow safety guidelines. Third, largely follow guidelines based on adequately powered RCTs with clinical outcomes. Lastly, individualize the use of all other guidelines to each specific patient, rather than blindly following them in all patients.
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